SAN DIEGO, September 10, 2024--DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, today announced the Dexcom G6 Continuous Glucose ...

“Now, our t:slim X2 users in Canada can have access to a range of innovative tools that not only simplify diabetes management but also enhance their quality of life.” “Through our continued ...

if a person with diabetes used the company’s G7 sensor and app to share their glucose data with healthcare providers or family members. Dexcom had taken Abbott to court in the EU in early 2024 ...

(Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by Health Canada, in-warranty t:slim X2™ insulin pump users can now access full compatibility with both ...

DexCom faces challenges in 2024 due to competition ... The potential for the launch of the G7 with a 15-day life rather than 10 days is quite appealing to DXCM investors. This would mean a boost ...

Dexcom tapped Google Cloud’s Vertex and Gemini AI models as the foundation for building its own proprietary platform. The Stelo sensor, meanwhile, first received an FDA clearance this past March ...

“Now, our t:slim X2 users in Canada can have access to a range of innovative tools that not only simplify diabetes management but also enhance their quality of life.” Dexcom’s G7 CGM features a 60% ...

In order from steepest decline to narrowest, the five unloved were Intel (NASDAQ: INTC), MongoDB (NASDAQ: MDB), Biogen (NASDAQ: BIIB), DexCom (NASDAQ: DXCM), and Microchip Technology (NASDAQ ...